Trevena (NASDAQ:TRVN) is scheduled to release its earnings data before the market opens on Tuesday, March 6th. Analysts expect Trevena to post earnings of ($0.27) per share for the quarter.
Trevena (NASDAQ TRVN) opened at $1.75 on Tuesday. The firm has a market capitalization of $109.03, a P/E ratio of -1.06 and a beta of -0.51. Trevena has a 52-week low of $1.34 and a 52-week high of $4.24. The company has a debt-to-equity ratio of 0.38, a current ratio of 4.92 and a quick ratio of 4.92.
An institutional investor recently raised its position in Trevena stock. California State Teachers Retirement System raised its position in shares of Trevena Inc (NASDAQ:TRVN) by 0.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 97,107 shares of the biopharmaceutical company’s stock after buying an additional 500 shares during the period. California State Teachers Retirement System owned about 0.16% of Trevena worth $223,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 52.97% of the company’s stock.
Trevena Company Profile
Trevena Inc is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused on commercializing it in the United States for use in acute care settings, such as hospitals and ambulatory surgery centers.
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.